ARQ-252

ARQ-252 · Arcutis Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARQ-252, covering 2024-04-05 to 2024-04-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema [Phase 1, Phase 2]